ALSUntangled update 3: Investigating stem cell transplants at the Hospital San Jose Tecnologico de Monterrey

Amyotrophic Lateral Sclerosis

Volumn 11, Issue 1-2, 2010, Pages 248-249

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN;

AMYOTROPHIC LATERAL SCLEROSIS; CLINICAL EFFECTIVENESS; EXPERIENCE; FOLLOW UP; HOSPITAL; HUMAN; IN VIVO STUDY; NERVE CELL; NEUROPROTECTION; PRIORITY JOURNAL; PUBLICATION; SHORT SURVEY; STEM CELL TRANSPLANTATION;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS; MEDICAL TOURISM; MEXICO; MOTOR CORTEX; PATIENT SATISFACTION; PROGRAM EVALUATION; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 77649308839     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482960903511872     Document Type: Short Survey

References (3)

1. Bedlack RS, Hardiman O. ALSUntangled (ALSU): a scientific approach to off-label treatment options for people with ALS using tweets and twitters. Amyotroph Lateral Scler. 2009;10:129-30.
2. www.alsworldwide.org/pdf/stem-cell-discussion.pdf
3. Martinez H, Gonzalez-Garza M, Moreno-Cuevas J, Caro E, Gutierrez-Jimenz E, Segura J. Stem-cell transplants into the frontal motor cortex in amyotrophic lateral sclerosis patients. Cytotherapy. 2009;11:26-34.